Skip to main content
. 2018 Oct 17;119(10):1223–1232. doi: 10.1038/s41416-018-0296-2

Fig. 4.

Fig. 4

a One week of combination therapy led to a dramatic increase in F4/80+ myeloid cells. b All mice treated with PLX4720 singly or in combination had a dramatic increase in TAMs, >98% of which were M1-polarised (F4/80+CD206IA/IE+), along with c. A dramatic decrease in monocytic MDSCs. N = 4 mice per group, repeated twice